Ventana's companion Dx to lung cancer drug wins Chinese approval

09/12/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems received approval in China for its Ventana ALK Rabbit Monoclonal Primary Antibody test, which is used to pinpoint patients with nonsmall cell lung cancer who are positive for the anaplastic lymphoma kinase fusion gene. The assay has been approved for use as a companion diagnostic test to Pfizer's lung cancer drug Xalkori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA